140 related articles for article (PubMed ID: 18572337)
1. Evaluation of CSF neurotransmitters and folate in 25 patients with Rett disorder and effects of treatment.
Temudo T; Rios M; Prior C; Carrilho I; Santos M; Maciel P; Sequeiros J; Fonseca M; Monteiro J; Cabral P; Vieira JP; Ormazabal A; Artuch R
Brain Dev; 2009 Jan; 31(1):46-51. PubMed ID: 18572337
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid concentrations of folate, biogenic amines and pterins in Rett syndrome: treatment with folinic acid.
Ormazabal A; Artuch R; Vilaseca MA; Aracil A; Pineda M
Neuropediatrics; 2005 Dec; 36(6):380-5. PubMed ID: 16429378
[TBL] [Abstract][Full Text] [Related]
3. Reduced folate transport to the CNS in female Rett patients.
Ramaekers VT; Hansen SI; Holm J; Opladen T; Senderek J; Häusler M; Heimann G; Fowler B; Maiwald R; Blau N
Neurology; 2003 Aug; 61(4):506-15. PubMed ID: 12939425
[TBL] [Abstract][Full Text] [Related]
4. S-adenosylmethionine and S-adenosylhomocysteine in plasma and cerebrospinal fluid in Rett syndrome and the effect of folinic acid supplementation.
Hagebeuk EE; Duran M; Abeling NG; Vyth A; Poll-The BT
J Inherit Metab Dis; 2013 Nov; 36(6):967-72. PubMed ID: 23392989
[TBL] [Abstract][Full Text] [Related]
5. Folinic acid supplementation in Rett syndrome patients does not influence the course of the disease: a randomized study.
Hagebeuk EE; Duran M; Koelman JH; Abeling NG; Vyth A; Poll-The BT
J Child Neurol; 2012 Mar; 27(3):304-9. PubMed ID: 21868372
[TBL] [Abstract][Full Text] [Related]
6. Fluoxetine rescues rotarod motor deficits in Mecp2 heterozygous mouse model of Rett syndrome via brain serotonin.
Villani C; Sacchetti G; Carli M; Invernizzi RW
Neuropharmacology; 2020 Oct; 176():108221. PubMed ID: 32652084
[TBL] [Abstract][Full Text] [Related]
7. Folinic acid treatment for schizophrenia associated with folate receptor autoantibodies.
Ramaekers VT; Thöny B; Sequeira JM; Ansseau M; Philippe P; Boemer F; Bours V; Quadros EV
Mol Genet Metab; 2014 Dec; 113(4):307-14. PubMed ID: 25456743
[TBL] [Abstract][Full Text] [Related]
8. CSF and urine biogenic amine metabolites in Rett syndrome.
Lekman A; Witt-Engerström I; Holmberg B; Percy A; Svennerholm L; Hagberg B
Clin Genet; 1990 Mar; 37(3):173-8. PubMed ID: 1691058
[TBL] [Abstract][Full Text] [Related]
9. First report of an unusual novel double mutation affecting the transcription repression domain of MeCP2 and causing a severe phenotype of Rett syndrome: Molecular analyses and computational investigation.
Ghorbel R; Ghorbel R; Rouissi A; Fendri-Kriaa N; Ben Salah G; Belguith N; Ammar-Keskes L; Gouider-Khouja N; Fakhfakh F
Biochem Biophys Res Commun; 2018 Feb; 497(1):93-101. PubMed ID: 29421650
[TBL] [Abstract][Full Text] [Related]
10. Effects of anticonvulsant treatment and low levels of folate and thiamine on amine metabolites in cerebrospinal fluid.
Botez MI; Young SN
Brain; 1991 Feb; 114 ( Pt 1A)():333-48. PubMed ID: 1705463
[TBL] [Abstract][Full Text] [Related]
11. Low CSF HVA levels in the Rett syndrome: a reflection of restricted synapse formation?
Nielsen JB; Bertelsen A; Lou HC
Brain Dev; 1992 May; 14 Suppl():S63-5. PubMed ID: 1378245
[TBL] [Abstract][Full Text] [Related]
12. Rett syndrome: model of neurodevelopmental disorders.
Percy AK; Lane JB
J Child Neurol; 2005 Sep; 20(9):718-21. PubMed ID: 16225824
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and clinical effects of tyrosine and tryptophan in the Rett syndrome.
Nielsen JB; Lou HC; Andresen J
Brain Dev; 1990; 12(1):143-7. PubMed ID: 1693042
[TBL] [Abstract][Full Text] [Related]
14. Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors.
Sheline Y; Bardgett ME; Csernansky JG
J Clin Psychopharmacol; 1997 Feb; 17(1):11-4. PubMed ID: 9004051
[TBL] [Abstract][Full Text] [Related]
15. Folate and monoamine metabolism in epilepsy.
Reynolds EH; Chadwick D; Jenner P; Chanarin I
J Neurol Sci; 1975 Dec; 26(4):605-15. PubMed ID: 1206436
[TBL] [Abstract][Full Text] [Related]
16. Effect of folic acid combined with fluoxetine in patients with major depression on plasma homocysteine and vitamin B12, and serotonin levels in lymphocytes.
Resler G; Lavie R; Campos J; Mata S; Urbina M; García A; Apitz R; Lima L
Neuroimmunomodulation; 2008; 15(3):145-52. PubMed ID: 18716414
[TBL] [Abstract][Full Text] [Related]
17. MECP2 mutations in Czech patients with Rett syndrome and Rett-like phenotypes: novel mutations, genotype-phenotype correlations and validation of high-resolution melting analysis for mutation scanning.
Zahorakova D; Lelkova P; Gregor V; Magner M; Zeman J; Martasek P
J Hum Genet; 2016 Jul; 61(7):617-25. PubMed ID: 26984561
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal Fluid Pterins, Pterin-Dependent Neurotransmitters, and Mortality in Pediatric Cerebral Malaria.
Rubach MP; Mukemba JP; Florence SM; Lopansri BK; Hyland K; Simmons RA; Langelier C; Nakielny S; DeRisi JL; Yeo TW; Anstey NM; Weinberg JB; Mwaikambo ED; Granger DL
J Infect Dis; 2021 Oct; 224(8):1432-1441. PubMed ID: 33617646
[TBL] [Abstract][Full Text] [Related]
19. Reduction of biogenic amine levels in the Rett syndrome.
Zoghbi HY; Percy AK; Glaze DG; Butler IJ; Riccardi VM
N Engl J Med; 1985 Oct; 313(15):921-4. PubMed ID: 2412119
[TBL] [Abstract][Full Text] [Related]
20. The Incidence and Evolution of Parkinsonian Rigidity in Rett Syndrome: A Pilot Study.
Humphreys P; Barrowman N
Can J Neurol Sci; 2016 Jul; 43(4):567-73. PubMed ID: 27050783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
